Wojnicz, D.; Korzekwa, K.; Guźniczak, M.; Wernecki, M.; Ulatowska-Jarża, A.; Buzalewicz, I.; Tichaczek-Goska, D.
Can α-Mangostin and Photodynamic Therapy Support Ciprofloxacin in the Inactivation of Uropathogenic Escherichia coli and Staphylococcus aureus Strains? Int. J. Mol. Sci. 2025, 26, 76.
https://doi.org/10.3390/ijms26010076
AMA Style
Wojnicz D, Korzekwa K, Guźniczak M, Wernecki M, Ulatowska-Jarża A, Buzalewicz I, Tichaczek-Goska D.
Can α-Mangostin and Photodynamic Therapy Support Ciprofloxacin in the Inactivation of Uropathogenic Escherichia coli and Staphylococcus aureus Strains? International Journal of Molecular Sciences. 2025; 26(1):76.
https://doi.org/10.3390/ijms26010076
Chicago/Turabian Style
Wojnicz, Dorota, Kamila Korzekwa, Mateusz Guźniczak, Maciej Wernecki, Agnieszka Ulatowska-Jarża, Igor Buzalewicz, and Dorota Tichaczek-Goska.
2025. "Can α-Mangostin and Photodynamic Therapy Support Ciprofloxacin in the Inactivation of Uropathogenic Escherichia coli and Staphylococcus aureus Strains?" International Journal of Molecular Sciences 26, no. 1: 76.
https://doi.org/10.3390/ijms26010076
APA Style
Wojnicz, D., Korzekwa, K., Guźniczak, M., Wernecki, M., Ulatowska-Jarża, A., Buzalewicz, I., & Tichaczek-Goska, D.
(2025). Can α-Mangostin and Photodynamic Therapy Support Ciprofloxacin in the Inactivation of Uropathogenic Escherichia coli and Staphylococcus aureus Strains? International Journal of Molecular Sciences, 26(1), 76.
https://doi.org/10.3390/ijms26010076